Business ❯ Market Analysis ❯ Stock Performance

Investor Relations

Market Reactions Shareholder Value Pfizer Stock Earnings Reports Nvidia Shareholder Returns Nestlé Shareholder Communications Super Micro Computer Oracle Stock AMC Stock Uber Stock SoundHound AI Hertz Global Holdings Dividend Kings DBS Valuation Shareholder Meetings Tesla Needham & Co. Company Outlook John Deere Earnings Call Buybacks Price Targets Earnings Guidance Palantir Technologies Analyst Ratings Company Valuation Company News CarMax Delivery Estimates Nike Nike Inc. Market Trends After-Hours Trading Shareholder Reactions Peloton Eli Lilly Loss Recovery Financial Results Shareholder Communication Post Holdings Stock Financial Forecasting 3M

Pfizer Tops Q1 Forecasts on Eliquis Strength, Reaffirms 2026 Outlook

Management signals a steady course for the year by leaning on new and acquired drugs.

Law Firms Press Soleno Investors to Seek Lead Role in Securities Suit by May 5

Peloton Shares Sink After Weak Holiday Quarter and Soft Sales Outlook

Sanofi Pushes Amlitelimab Toward 2026 Filings After Mixed Phase 3 Readouts

Lead-Plaintiff Deadline Nears in StubHub IPO Class Action

Microchip Lifts Q3 Sales Outlook to About $1.185 Billion on Booking Strength

Diageo to Sell 65% of East African Breweries to Asahi for $2.3 Billion

James Hardie Investors Face Dec. 23 Deadline in Securities Suit Over Alleged North America Channel Misstatements

ExxonMobil Lifts 2030 Profit Targets, Scales Back Low-Carbon Spending

Molson Coors Elevates Strategy Chief Rahul Goyal to CEO on Oct. 1

Deere Cuts 2025 Profit Outlook Again as Tariffs, Weak Demand Weigh on Q3 Results